Russia’s Sputnik V gets Emergency Use authorisation nod in India
New Delhi: Russia’s Sputnik V got approval from the Subject expert committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to...
Serum Institute of India
Vaccine demand up, but cos to take some weeks to up output
With a number of states complaining of vaccine shortage and temporarily shutting centres – at a time when the need is to increase the daily...
Serum Institute of India, with its production ‘very stressed,’ asks government to help boost production
With its production capacity “very stressed,” the world’s largest producer of vaccines is seeking relief from its government. The Serum Institute of India has requested...
India’s Serum Institute asks government for $403 million to boost AstraZeneca vaccine output
New Delhi: The Serum Institute of India, the world’s biggest vaccine manufacturer, has asked the government for a grant of 30 billion rupees ($402.97 million)...
AstraZeneca sends legal notice to SII over delays in vax supply
Mumbai: The UK-headquartered drug firm AstraZeneca has served a legal notice to its manufacturing partner, Pune-based Serum Institute of India, over delays in the supply...
SII to start supplying 1st made-in-India pneumococcal conjugate vaccine to Centre from Wednesday
The Serum Institute of India (SII) will start supplying the first indigenously developed pneumococcal conjugate vaccine to the Centre from Wednesday, sources said on Tuesday....
Covid-19: More Indian companies could begin manufacturing Sputnik vaccine
India is poised to become a manufacturing hub for Russia’s Covid-19 vaccine, Sputnik V, as it inches towards getting an approval from India’s drug regulator....
India pushes ahead with coronavirus vaccination drive to head off new surge
By Rajendra Jadhav and Rupam Jain SHRI DUNGARGARH/SATARA, India, – Asli Bai Sayat, 72, had to travel for two hours on a camel cart to...
Covovax trials begin in India, hope to launch it by Sept : Adar Poonawalla
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of Covid-19 vaccine Covovax have begun in India and the...
Assure of no concerns in this regard: Health ministry over AstraZeneca vaccine’s ‘blood clot’ reports
NEW DELHI: There is no signal of concern against AstraZeneca‘s Covid vaccine, the Union health ministry assured on Wednesday amid reports of blood clot fears....